CAS 379-79-3
:Ergotamine tartrate
Description:
Ergotamine tartrate is a pharmaceutical compound derived from ergot alkaloids, primarily used in the treatment of migraine headaches. It is a semi-synthetic derivative of ergotamine, which is obtained from the fungus Claviceps purpurea. This compound is characterized by its ability to constrict blood vessels, thereby alleviating migraine symptoms. Ergotamine tartrate is typically administered in the form of tablets or sublingual formulations, allowing for rapid absorption and onset of action. The substance is known for its potential side effects, including nausea, vomiting, and cardiovascular complications, particularly when used inappropriately or in excessive doses. It acts primarily as a selective agonist for serotonin receptors, particularly the 5-HT1B and 5-HT1D subtypes, which play a crucial role in regulating vascular tone and neurotransmitter release. Due to its pharmacological properties, ergotamine tartrate is classified as a controlled substance in some jurisdictions, necessitating careful monitoring and prescription by healthcare professionals.
Formula:C33H35N5O5C4H6O6
InChI:InChI=1S/C33H35N5O5.C4H6O6/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t21-,25-,26+,27+,32-,33+;1-,2-/m11/s1
InChI key:InChIKey=NMTWKEWYQXZGCI-LYOWLMOVSA-N
SMILES:O[C@@]12N([C@@H](CC3=CC=CC=C3)C(=O)N4[C@]1(CCC4)[H])C(=O)[C@@](NC(=O)[C@@H]5C=C6C=7C=8C(C[C@]6(N(C)C5)[H])=CNC8C=CC7)(C)O2.[C@@H]([C@H](C(O)=O)O)(C(O)=O)O
Synonyms:- (5'Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxoergotaman 2,3-Dihydroxybutanedioate (1:1)
- (5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-Ergotaman-3',6',18-trione, [R-(R*,R*)]-2,3-dihydroxybutanediate (2:1) (salt)
- Ergam
- Ergate
- Ergomar
- Ergostat
- Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
- Ergotamine Bitartrate
- Ergotamine, tartrate (2:1) (salt)
- Ergotartrat
- Etin
- Exmigra
- Femergin
- Gotamine
- Gotamine tartrate
- Gynergen
- Gynergin
- Lingraine
- Lingran
- Medihaler-ergotamine
- NSC 41869
- Neo-Ergotin
- Rigetamin
- Secagyn
- Secupan
- Ergotamine tartrate
- ergotaminebitartrate
- ergotartrate
- 6’,18-trione,12’-hydroxy-2’-methyl-5’-(phenylmethyl)-ergotaman-3(5’alpha)
- -,[theta-(theta,theta)]-2,3-dihydroxybutanedioate(2:1)(salt)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Ergotamine D-tartrate
CAS:Controlled Product<p>Ergotamine D-tartrate is a drug that belongs to the group of nonsteroidal anti-inflammatory drugs. It is used in the treatment of migraine and other headaches. Ergotamine D-tartrate inhibits the production of nitric oxide, which has been shown to be involved in the process of angiogenesis. This drug also has long-term efficacy for headaches and migraines, as well as an anti-migraine effect. Ergotamine D-tartrate binds to specific receptors on neurons called alpha2 adrenergic receptors, which are located on blood vessels in the brain and have been implicated in migraine pathophysiology. These receptors are not present on vessels elsewhere in the body, which makes ergotamine a more selective drug for migraine than other nonsteroidal anti-inflammatory drugs.</p>Formula:(C33H35N5O5)2•C4H6O6Purity:Min. 95%Molecular weight:1,313.44 g/molERGOTAMINE TARTRATE CRS - * DRUG PRECURSOR
CAS:Controlled ProductERGOTAMINE TARTRATE CRS - * DRUG PRECURSORFormula:C70H76N10O16Color and Shape:PowderMolecular weight:1313.41ERGOTAMINE FOR SYSTEM SUITABILITY CRS - * DRUG PRECURSOR (ERGOTAMINE TARTRATE)
CAS:Controlled ProductERGOTAMINE FOR SYSTEM SUITABILITY CRS - * DRUG PRECURSOR (ERGOTAMINE TARTRATE)Formula:C70H76N10O16Color and Shape:PowderMolecular weight:1313.41ERGOTAMINE TARTRATE RS - * DRUG PRECURSOR
CAS:Controlled ProductERGOTAMINE TARTRATE RS - * DRUG PRECURSORFormula:C70H76N10O16Color and Shape:PowderMolecular weight:1313.41Ergotamine Tartrate
CAS:Controlled ProductErgotamine and its saltsFormula:(C33H35N5O5)2·C4H6O6Color and Shape:White Yellow PowderMolecular weight:1162.52764






